Condition

COVID-19 (2)

SARS-CoV-2 Infection (2)

Coronavirus Infection (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

BioNTech SE (1)

Sean Collins (1)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Institutes of Health (NIH) (1)

Pfizer (1)

Intervention

placebo (2)

bnt162b2 (1)

bnt162b2 omi (1)

combination (bivalent) bnt162b2 and bnt162b2 omi (1)

combination bnt162b2 and bnt162b2 omi (1)

fostamatinib (1)

trv027 (1)

txa127 (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

SARS-CoV-2 Infection

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting

COVID-19
+2 more

TXA127
+3 more

Birmingham, Alabama
+68 more

Jan 24, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting

SARS-CoV-2 Infection
COVID-19

BNT162b2
+4 more

Athens, Alabama
+158 more

Jul 18, 2022